05-Dec-2017 By Dan Stanton
Roche, Merck and Lilly are among those calling for regulatory harmonisation and free movement of goods between the EU and the UK once the latter leaves the Union.
09-Jan-2017 By Dan Stanton
Drugmakers must include a transaction identification number when buying or selling machinery for tabletting or encapsulating controlled substances, according to a final ruling from the US DEA.
27-Oct-2016 By Gareth Macdonald
Development of an EMA and US FDA mutual recognition agreement on drug facility inspections has progressed according to European Commission negotiators who say a deal could be signed by January.
11-Aug-2016 By Gareth Macdonald
SRF Limited has unveiled plans for a second chloromethane plant just two months after India imposed anti-dumping tariffs on Chinese and Russian imports.
08-Jun-2016 By Gareth Macdonald
Parties negotiating TTIP have discussed measures that would end EMA API and drug manufacturing plant inspections in the US and FDA inspections in Europe.
10-Dec-2015 By Dan Stanton
A new system will simplify and speed-up US imports of pharma ingredients the FDA says, but industry needs to be on board by the end of February.
Dispatches from CPhI
15-Oct-2015 By Dan Stanton
Big Pharma has returned to Europe for its API sourcing due to reasons of quality and reliability, according to the European Fine Chemicals Group (EFCG).
31-Mar-2015 By Gareth Macdonald
Ensuring drugs, APIs and excipients are safe will be a focus for the EMA, which says it will explore supplier inspection databases and using trade deals like TTIP to promote GMP standards globally.
Dispatches from InformEx
09-Feb-2015 By Zachary Brennan
Pharmaceutical and chemical manufacturers may have to wait until 2017 to see the benefits of the Transatlantic Trade and Investment Partnership, VP of SOCMA (Society of Chemical Manufacturers and Affiliates) told attendees at InformEx in New Orleans.
10-Dec-2014 By Gareth Macdonald
An ex-GSK staffer charged with winning manufacturing investments for the UK says fostering innovation and “fiscal attractiveness” are vital.
18-Aug-2014 By Gareth Macdonald
US authorities are reviewing a Neolpharma request for tax breaks for APIs imported to a former Pfizer-owned plant it operates in Puerto Rico.
People on the Move
03-Feb-2014 By Fiona Barry
This week's People on the Move column sees leadership appointments at two major trade bodies, as well as senior hires at Sartorius and ImmunoGen.
22-Jul-2013 By Gareth Macdonald
Import duties on some pharma intermediates could be suspended temporarily under legislation being debated in the US House of Representatives.
24-Jun-2013 By Zachary Brennan
Roselabs Bioscience has invested $67M into a pre-filled syringe facility in India and is exploring the option of exporting the products to 35 countries in unregulated markets in southeast Asia, Latin America and Africa.
Indian Plans to hand quality oversight of APIs shipped to Europe to ‘competent authority’ are still being discussed according to Pharmexcil.
All Indian pharma exports to require barcodes from July
20-Jan-2011 By Nick Taylor
All Indian pharma exports will soon require barcodes on primary, secondary and tertiary packaging as part of anti-counterfeiting efforts.
'Chindia' could become global generic powerhouse
22-Dec-2010 By Alexandria Pešić
China’s PM Wen Jiabao has vowed to improve market access for Indian pharmaceutical companies to better supply global generic drug needs.
EU & India resolve generic drug seizures dispute; reports
13-Dec-2010 By Nick Taylor
The EU and India have resolved a dispute about the seizure of generic medicines passing through Europe on route to Africa and Latin America, according to reports.
ACTA finalised amid claims it creates trade barriers
24-Nov-2010 By Nick Taylor
ACTA was finalised last week but controversies remain, with research warning it could “create significant barriers to international trade, especially in generic medicines”.
Visualising UK pharma
18-May-2010 By Nick Taylor
in-PharmaTechnologist presents an overview of the UK pharma sector, using interactive maps and graphs to give an insight into its composition and how it has changed in recent years.
Reimportation is “legislative madness”
19-Nov-2009 By Nick Taylor
It is “legislative madness” to allow reimportation in the US, according to the chair of EAASM who spoke at AAPS about Europe’s “porous supply chain” and how it could affect the standard of medicines in the States.
WHO told to ponder patents, counterfeits and international trade
24-Feb-2009 By Nick Taylor
Shipments of drugs that do not violate patent rights in the exporting or importing countries should not be seized in transit or labeled as counterfeit, as occurred recently, according to health advocates.
German laboratory equipment market
09-Oct-2007 By Dr Matt Wilkinson
Sales of laboratory products in Germany have recovered from a
'stagnant period' between 2001 and 2004 to reach a record €5.3bn in
Award for preclinical services firm
22-Aug-2007 By staff reporter
Domainex, a London- and Cambridge-based preclinical services firm
has won an industry award for its bottleneck-breaking genomics
South Korea acts to save its pharma industry from US competition
03-Jul-2007 By Katrina Megget
South Korea is to inject about one trillion won ($1.07bn) into its
pharmaceutical industry to give it a rev up as the newly signed
free trade agreement (FTA) with the US comes into force.
Russians left in the dark despite lifted export ban
20-Jun-2007 By Emilie Reymond
Despite a lift of the ban on biological sample transportation out
of Russia, the country's clinical research industry is still in the
dark on the new rules to control export of such materials.
Government actions 'hindering Pakistan's drug industry'
Efforts by Pakistan to build a pharmaceutical sector to rival that
of neighbouring India are being undermined by regulatory
interference, according to representatives of the domestic drug
China to review catechol imports
The Ministry of Commerce in China has that it plans to review the
five-year programme of anti-dumping duties it set on catechol
imports from the European Union.
Trade dress victory for re-packagers
In Norway, the Supreme Court has concluded that the packaging
designused by the local subsidiary of parallel importer Paranova
does notinfringe Merck & Co's trademarks.
FDA opens new comment period on bioterrorism regs
The US Food and Drug Administration has started a new comment
period on its bioterrorism regulations - designed to safeguard the
national food supply - which will have a significant impact on
companies importing pharmaceutical excipients...
Chinese packaging industry about to boom
China's packaging industry is currently undergoing a growth rate
that is set to turn the sector into one of the country's leading
industries, report Simon Pitman and Phil Taylor.
Chinese chemical industry heads for consolidation?
Compared with European and US chemical companies, most domestic
Chinese chemical enterprises have remained technologically
challenged with productivity lagging behind international levels.
Packaging ruling a victory for parallel traders
Companies involved in the parallel trade of pharmaceuticals have
been boosted by a court ruling which gives them the right to re-box
products shipped into the UK from another country in the European
Pharma even more important to UK
The pharmaceutical industry's contribution to the UK's trade
balance has jumped by nearly a quarter in the first six months of
this year compared with the same period in 2002, figures released
today by the Association of...